C5a Receptor Antagonist, linear, human, rat – 1 mg

Overview

The C5a Receptor Antagonist is a linear peptide derived from the C-terminus of the chemokine complement fragment 5 anaphylatoxin (C5a). This peptide plays a crucial role in inhibiting the binding and function of C5a at both human and rat C5a receptors. C5a is essential for triggering cellular immune responses, and its overexpression is implicated in various immunoinflammatory diseases such as arthritis, Alzheimer’s disease, cystic fibrosis, and systemic lupus erythematosus. If you’re looking for a reliable solution for your research in immunology, our C5a Receptor Antagonist is the perfect choice.

Key Features

• Linear peptide derived from C5a.
• Inhibits C5a receptor binding.
• Applicable for both human and rat models.
• Supports research into autoimmune and inflammatory conditions.
• Comes in a convenient 1 mg vial.

Specifications

FAQ

What is the function of the C5a Receptor Antagonist?

The C5a Receptor Antagonist inhibits the binding of C5a to its receptors, thereby modulating immune responses linked to inflammatory diseases.

Can this peptide be used in both human and rat studies?

Yes, this peptide is effective for both human and rat models, making it versatile for various research applications.

How should I store the C5a Receptor Antagonist?

We recommend storing this product at -20°C for optimal stability and efficacy. Always refer to the product label for detailed storage instructions.

For those involved in studying molecular interactions or developing assays, our PKG Substrate or Autocamtide-2 may complement your research effectively. Don’t hesitate to explore our range of Peptides for more innovative products.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled